| 发明名称 |
COMBINATION THERAPY USING TRANSFERRIN FUSION PROTEINS COMPRISING GLP-1. |
| 摘要 |
<p>The present invention provides combination therapy comprising transferrin fusion protein and DPP-IV inhibitors and/or neutral endopeptidase (NEP) inhibitors. The transferrin fusion protein comprises therapeutic polypeptides or peptides useful in the treatment of diseases such as diabetes.</p> |
| 申请公布号 |
MX2007001424(A) |
申请公布日期 |
2008.03.13 |
| 申请号 |
MX20070001424 |
申请日期 |
2005.08.03 |
| 申请人 |
BIOREXIS PHARMACEUTICAL CORPORATION |
发明人 |
HOMAYOUN SADEGHI;CHRISTOPHER PRIOR;DAVID J. BALLANCE |
| 分类号 |
A61K51/06;A61K51/08 |
主分类号 |
A61K51/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
